AGP Picks
View all

Health Monitor Malta
Provided by AGP

Health Monitor Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Malta.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 19, 2026

Le Bioadaptateur DynamX® d’Elixir Medical démontre une réduction significative des taux d’événements coronariens par rapport à un stent à élution médicamenteuse
May 19, 2026

Le Bioadaptateur DynamX® d’Elixir Medical démontre une réduction significative des taux d’événements coronariens par rapport à un stent à élution médicamenteuse

Indeterminate GlobeNewswire
EuroPCR 2026: DynamX® Bioadaptor di Elixir Medical mostra tassi di eventi significativamente inferiori rispetto allo stent a rilascio di farmaco
May 19, 2026

EuroPCR 2026: DynamX® Bioadaptor di Elixir Medical mostra tassi di eventi significativamente inferiori rispetto allo stent a rilascio di farmaco

Indeterminate GlobeNewswire
EuroPCR 2026: Bioadaptator DynamX® firmy Elixir Medical wykazuje istotne obniżenie występowania zdarzeń niepożądanych
May 19, 2026

EuroPCR 2026: Bioadaptator DynamX® firmy Elixir Medical wykazuje istotne obniżenie występowania zdarzeń niepożądanych

Indeterminate GlobeNewswire
Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026
May 19, 2026

Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026

Indeterminate GlobeNewswire
Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
May 19, 2026

Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results

Indeterminate GlobeNewswire
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
May 19, 2026

Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies

Indeterminate GlobeNewswire
Clearmind Medicine Announces 1-for-10 Reverse Share Split
May 19, 2026

Clearmind Medicine Announces 1-for-10 Reverse Share Split

Indeterminate GlobeNewswire
GenoSafe advances CLIA pathway for transatlantic ATMP development
May 19, 2026

GenoSafe advances CLIA pathway for transatlantic ATMP development

Indeterminate GlobeNewswire
HEPHAISTOS-Pharma appoints Stephan Braun as Chief Medical Officer to lead clinical development strategy
May 19, 2026

HEPHAISTOS-Pharma appoints Stephan Braun as Chief Medical Officer to lead clinical development strategy

Indeterminate GlobeNewswire
FEATOL Introduces Ergonomic Wrist Support for Modern Repetitive Strain Challenges
May 19, 2026

FEATOL Introduces Ergonomic Wrist Support for Modern Repetitive Strain Challenges

Indeterminate GlobeNewswire
Mabylon Reports Positive Phase Ia Results in MY006 Peanut Allergy Trial and Initiates Phase Ib Patient Part of the Study; Advances Tree Pollen Allergy Program MY010 toward Clinical Development
May 19, 2026

Mabylon Reports Positive Phase Ia Results in MY006 Peanut Allergy Trial and Initiates Phase Ib Patient Part of the Study; Advances Tree Pollen Allergy Program MY010 toward Clinical Development

Indeterminate GlobeNewswire
AdrenoMed Highlights Need for Personalized Therapies in Septic Shock Amid New Sepsis Guidelines and U.S. Policy Initiative
May 19, 2026

AdrenoMed Highlights Need for Personalized Therapies in Septic Shock Amid New Sepsis Guidelines and U.S. Policy Initiative

Indeterminate GlobeNewswire
Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer
May 19, 2026

Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer

Indeterminate GlobeNewswire
Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial
May 19, 2026

Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial

Indeterminate GlobeNewswire
Unaudited Preliminary Results for the Year Ended December 31, 2025
May 19, 2026

Unaudited Preliminary Results for the Year Ended December 31, 2025

Indeterminate GlobeNewswire
Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID Fatigue
May 19, 2026

Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID Fatigue

Indeterminate GlobeNewswire
ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026
May 19, 2026

ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026

Indeterminate GlobeNewswire
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

Indeterminate GlobeNewswire
Rapid Nutrition Advances Finalization of Australian Flagship Initiative
May 19, 2026

Rapid Nutrition Advances Finalization of Australian Flagship Initiative

Indeterminate GlobeNewswire
Fangzhou Ranked among 2025 Guangzhou AI Innovation “Most Promising Enterprises” for AI‑Powered Chronic Disease Services
May 19, 2026

Fangzhou Ranked among 2025 Guangzhou AI Innovation “Most Promising Enterprises” for AI‑Powered Chronic Disease Services

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Health Monitor Malta

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.